Click to Share
 

Cnpr Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By NAPSRx
Eli Lilly has entered into an exclusive license agreement with Hanmi Pharmaceutical Co., Ltd. to develop and commercialize Hanmi's oral Bruton's tyrosine kinase (BTK) inhibitor, HM71224, for the treatment of autoimmune and other diseases.
12391125
By NAPSRx
According to a new study published in the journal Neuropharmacology conducted by research academics at Lancaster University, certain type 2 diabetes drugs on the market have produced neuroprotective effects in a mouse model of Alzheimer's disease.
By NAPSRx
The new collaborative effort to develop a single tablet for HIV treatment by industry leaders J &J and Glaxo (Viiv Healthcare) could significantly improve the lives of HIV patients, if successful.
By NAPSRx
A study by Belgian doctoral researcher Wouter De Haes (KU Leuven) and colleagues provides new evidence that metformin, the world's most widely used anti-diabetic drug, slows ageing and increases lifespan.
By NAPSRx
After the markets closed Friday, Amgen and AstraZeneca announced that their top psoriasis contender, brodalumab, scored a win in Phase III, with a large majority of patients in both dosage arms clearing the bar on a standard measure for efficacy.
By NAPSRx
Sales of the Bayer Group advanced by 2.8% in the first quarter of 2014 to $15 million and business expanded by 8.4%. EBIT rose by 18.4% to $3 million after net special items of plus $9.7 million.
By NAPSRx
Novartis has won early FDA approval for their new drug; Zykadia.
By NAPSRx
Novartis announced that it had reached definitive agreements with GlaxoSmithKline plc (GSK) and Eli Lilly and Company (Lilly) on a set of transactions.
By NAPSRx
U.S. drugmaker AbbVie Inc reported better-than-expected quarterly sales and earnings, fueled by a sizzling performance from its Humira treatment for rheumatoid arthritis, the world's top-selling prescription medicine.
By NAPSRx
A team of researchers from Columbia University Medical Center (CUMC), Weill Cornell Medical College, and Brandeis University has devised a wholly new approach to the treatment of Alzheimer's disease involving the so-called retromer protein complex.
By NAPSRx
Pfizer Inc. (PFE), the world’s biggest drugmaker, held informal, now-discontinued talks with AstraZeneca Plc about possibly buying the London-based maker of asthma and heart drugs, said two people familiar with the matter.
By NAPSRx
GlaxoSmithKline (GSK) has received approval from the US Food and Drug Administration (FDA) for its Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adult patients with type 2 diabetes.
By NAPSRx
A sharp drop in the number of young women infected with the two strains of human papillomavirus (HPV) most likely to cause cervical cancer occurred in England after the 2008 launch of a national vaccination program there, a new study shows.
By NAPSRx
Plans for a new type of DNA vaccine to protect against the deadly HIV and Hepatitis C viruses have taken an important step forward, with University of Adelaide researchers applying for a patent based on groundbreaking new research.
By NAPSRx
GSK and J&J have released a new AIDS drug to transform the outlook of the disease. New pharmaceutical candidates will be needed for proper promotion of these products to various markets.
By NAPSR
Researchers at the University of Illinois at Chicago have developed a system for precisely delivering anti-inflammatory drugs to immune cells gone out of control, while sparing their well-behaved counterparts.
By NAPSR
According to the Centers for Disease Control, more than two million people come down with antibiotic-resistant infections annually, and at least 23,000 die because their treatment can't stop the infection. In addition, the pipeline for new antibiotic
By NAPSR
Artificial bone marrow may be used to reproduce hematopoietic stem cells. A prototype has now been developed by scientists of KIT, the Max Planck Institute for Intelligent Systems, Stuttgart, and Tübingen University (Germany).
By NAPSR
Pfizer Inc. reported financial results for third-quarter 2013. Reported revenues decreased $310 million, or 2%, which reflects an operational decline of $38 million, or less than 1%, and the unfavorable impact of foreign exchange of $272 m
By NAPSR
University of Miami Miller School of Medicine researchers played a key role in the largest international Alzheimer's disease genetics collaboration, which identified 11 new regions of the genome that contribute to late-onset Alzheimer's disease.

All Press Releases

By NAPSRx
Valeant Pharmaceutical’s wholly owned subsidiary, Salix Pharmaceuticals, Inc received approval from the U.S. Food and Drug Administration (FDA) for Xifaxan® 550 mg to treat IBS-D (Irritable Bowel Syndrome with Diarrhea) in adults.
By NAPSRx
Eli Lilly has entered into an exclusive license agreement with Hanmi Pharmaceutical Co., Ltd. to develop and commercialize Hanmi's oral Bruton's tyrosine kinase (BTK) inhibitor, HM71224, for the treatment of autoimmune and other diseases.
By NAPSRx
The U.S. Food and Drug Administration has approved Roche’s Lucentis for the treatment of diabetic retinopathy (DR), in people with diabetic macular edema (DME).
By NAPSRx
Incyte Corporation has received approval for Jakafi® (ruxolitinib), the first and only FDA-approved oral medication for patients with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea.
12391125
By NAPSRx
According to a new study published in the journal Neuropharmacology conducted by research academics at Lancaster University, certain type 2 diabetes drugs on the market have produced neuroprotective effects in a mouse model of Alzheimer's disease.
By NAPSRx
With the USA accounting for 34% of the world's pharmaceuticals, representatives are needed to promote new products coming down the pipeline. Meet job requirements with the NAPSRx's pharmaceutical sales training.
By NAPSRx
Pharmaceutical Sales is one of the highest paid professions in sales and earnings are expected to increase in the coming years. Now is the time to get into this amazing field.
By NAPSRx
The new collaborative effort to develop a single tablet for HIV treatment by industry leaders J &J and Glaxo (Viiv Healthcare) could significantly improve the lives of HIV patients, if successful.
By NAPSRx
A study by Belgian doctoral researcher Wouter De Haes (KU Leuven) and colleagues provides new evidence that metformin, the world's most widely used anti-diabetic drug, slows ageing and increases lifespan.
By NAPSRx
Eli Lilly and Co. said its Type II diabetes drug was more effective than Sanofi SA's approved drug Lantus in reducing patients' blood sugar levels in 3 late-stage trials.
By NAPSRx
After the markets closed Friday, Amgen and AstraZeneca announced that their top psoriasis contender, brodalumab, scored a win in Phase III, with a large majority of patients in both dosage arms clearing the bar on a standard measure for efficacy.
By NAPSRx
Sales of the Bayer Group advanced by 2.8% in the first quarter of 2014 to $15 million and business expanded by 8.4%. EBIT rose by 18.4% to $3 million after net special items of plus $9.7 million.
By NAPSRx
In the latest deal in the pharmaceutical space, Germany-based Bayer is acquiring Merck's consumer care business, which includes well-known brands like Claritin, Afrin and Coppertone, for $14.2 billion.
By NAPSRx
The roll-out of Novo Nordisk's ultra-long-acting insulin Tresiba is off to an encouraging start, picking up sales of around $15 million USD in the first quarter of the year.
By NAPSRx
Novartis has won early FDA approval for their new drug; Zykadia.
By NAPSRx
Actavis plc’s first quarter 2014 earnings came in at $3.49 per share, well above the Zacks Consensus Estimate of $3.29 per share and 75.4% above the year-ago earnings.
By NAPSRx
Novartis announced that it had reached definitive agreements with GlaxoSmithKline plc (GSK) and Eli Lilly and Company (Lilly) on a set of transactions.
By NAPSRx
U.S. drugmaker AbbVie Inc reported better-than-expected quarterly sales and earnings, fueled by a sizzling performance from its Humira treatment for rheumatoid arthritis, the world's top-selling prescription medicine.
By NAPSRx
Ritalin, a drug used to treat attention-deficit/hyperactivity disorder, may help people maintain self-control so they can stick to a diet or a boring project, a new study suggests.
By NAPSRx
A team of researchers from Columbia University Medical Center (CUMC), Weill Cornell Medical College, and Brandeis University has devised a wholly new approach to the treatment of Alzheimer's disease involving the so-called retromer protein complex.
By NAPSRx
Novartis and GSK to join forces in consumer healthcare, while Pfizer thought to be considering a $100bn bid for AstraZeneca
By NAPSRx
Pfizer Inc. (PFE), the world’s biggest drugmaker, held informal, now-discontinued talks with AstraZeneca Plc about possibly buying the London-based maker of asthma and heart drugs, said two people familiar with the matter.
By NAPSRx
The firm's consumer and medical-device group are lagging, but strong results from the pharmaceuticals side should drive earnings throughout this year and into 2015, says Morningstar's Damien Conover.
By NAPSRx
GlaxoSmithKline (GSK) has received approval from the US Food and Drug Administration (FDA) for its Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adult patients with type 2 diabetes.
By NAPSRx
A sharp drop in the number of young women infected with the two strains of human papillomavirus (HPV) most likely to cause cervical cancer occurred in England after the 2008 launch of a national vaccination program there, a new study shows.
By NAPSRx
Merck Serono, the biopharmaceutical division of Merck, announced that its U.S. affiliate EMD Serono has signed a research agreement with Pfizer Inc. and the Broad Institute in Cambridge, Massachusetts, U.S.
By NAPSRx
Plans for a new type of DNA vaccine to protect against the deadly HIV and Hepatitis C viruses have taken an important step forward, with University of Adelaide researchers applying for a patent based on groundbreaking new research.
By NAPSRx
The need for fresh pharmaceutical sales representatives will increase, along with the increase in sales growth for new pharmaceuticals that are in the market.
By NAPSRx
GSK and J&J have released a new AIDS drug to transform the outlook of the disease. New pharmaceutical candidates will be needed for proper promotion of these products to various markets.
By NAPSR
Researchers at the University of Illinois at Chicago have developed a system for precisely delivering anti-inflammatory drugs to immune cells gone out of control, while sparing their well-behaved counterparts.

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share